Genetic analysis links psychiatric conditions to shared roots

A large-scale genetic study of over a million people has identified five underlying genetic groups for 14 psychiatric conditions, suggesting many share common biological causes. This finding offers reassurance to those diagnosed with multiple disorders, indicating a single root cause rather than separate issues. The research highlights significant overlaps, such as between schizophrenia and bipolar disorder.

Researchers analyzed gene variants associated with 14 neurodivergencies and mental health conditions in more than a million individuals, marking the largest study of its kind. The results, published in Nature, reveal that these conditions cluster into five genetic groups rather than being entirely distinct.

Andrew Grotzinger at the University of Colorado Boulder, part of the research team, notes that this is encouraging for patients. "For the millions of people out there who are being diagnosed with multiple psychiatric conditions, this indicates that they don’t have multiple distinct things going on," he says. "I think it makes a big difference for a patient to hear that."

The study found high overlap between schizophrenia and bipolar disorder, with variants in genes active in excitatory neurons, which promote neuron firing. Similarly, major depression, post-traumatic stress disorder (PTSD), and anxiety share variants in genes linked to oligodendrocytes, cells that form myelin sheaths around nerves. Other groupings include attention deficit hyperactivity disorder (ADHD) and autism; obsessive-compulsive disorder (OCD), anorexia nervosa, and Tourette’s syndrome; and substance use disorders with nicotine dependence.

This genetic overlap may explain why two-thirds of people with one psychiatric diagnosis receive additional ones over their lifetime. Grotzinger compares it to diagnosing symptoms of a cold separately: "If you went to the doctor and you had a runny nose, a cough and a sore throat, you wouldn’t want to be diagnosed with runny nose disorder, coughing disorder and sore throat disorder. You’d want to be diagnosed with a cold."

"We’re giving separate labels to things that biologically are not very separable," he adds, though some clinicians argue treatments differ despite minor genetic distinctions.

Avshalom Caspi at Duke University praises the work: "This is an impressive paper. Many mental disorders are not separate disorders, but share common pathways that affect neurodevelopment, cognition and emotion. This is increasingly appreciated now."

Terrie Moffitt, also at Duke, urges shifting away from isolated studies: "Funders should be much more careful about giving grants to researchers who study one disorder at a time, lest a good deal of research resources be wasted."

Limitations include reliance on data from mostly European ancestry individuals and outdated collection methods. Grotzinger cautions against immediate applications like embryo screening, as the functions of these variants remain unclear.

Liittyvät artikkelit

Photorealistic illustration of a human brain interwoven with colorful DNA strands symbolizing shared genetic risks across 14 psychiatric disorders, based on a global study in Nature.
AI:n luoma kuva

Study maps shared genetic factors across 14 psychiatric disorders

Raportoinut AI AI:n luoma kuva Faktatarkistettu

A global genetics analysis has found extensive shared DNA risk across 14 psychiatric disorders, offering a clearer explanation for why many people receive multiple diagnoses over their lifetime. Using genomic data from more than six million individuals, researchers reported that the disorders cluster into five partially overlapping genetic groupings. The study was published Dec. 10, 2025, in Nature.

Researchers have developed a genomic mapping technique that reveals how thousands of genes work together to influence disease risk, helping to bridge gaps left by traditional genetic studies. The approach, described in a Nature paper led by Gladstone Institutes and Stanford University scientists, combines large-scale cell experiments with population genetics data to highlight promising targets for future therapies and deepen understanding of conditions such as blood disorders and immune-mediated diseases.

Raportoinut AI

A new genetic study has identified 331 genes essential for transforming stem cells into brain cells, including a novel gene linked to neurodevelopmental disorders. Led by scientists at the Hebrew University of Jerusalem, the research highlights how early genetic disruptions can lead to conditions like autism and developmental delay. The findings, published in Nature Neuroscience, also reveal patterns in how these disorders are inherited.

A new study on thousands of rats suggests that the genes of social partners can shape an individual's gut microbiome through shared microbes. Researchers found stronger genetic influences when accounting for these social effects. The findings highlight indirect ways genetics affect health via microbial exchange.

Raportoinut AI

A large-scale genetic analysis has revealed that reducing levels of specific Homer1 gene variants in mice improves attention by quieting brain activity. The research, published in Nature Neuroscience, suggests this approach could lead to novel treatments for ADHD and related disorders. The effect is most pronounced during a critical developmental period in adolescence.

Fathers in Sweden were less likely to receive new psychiatric diagnoses during their partner’s pregnancy and in the first months after birth, but diagnoses of depression and stress-related disorders rose by more than 30% toward the end of the child’s first year, according to a large national register study published in JAMA Network Open.

Raportoinut AI Faktatarkistettu

Researchers at the Icahn School of Medicine at Mount Sinai have developed an artificial intelligence system called V2P that not only assesses whether genetic mutations are likely to be harmful but also predicts the broad categories of disease they may cause. The approach, described in a paper in Nature Communications, is intended to accelerate genetic diagnosis and support more personalized treatment, particularly for rare and complex conditions.

 

 

 

Tämä verkkosivusto käyttää evästeitä

Käytämme evästeitä analyysiä varten parantaaksemme sivustoamme. Lue tietosuojakäytäntömme tietosuojakäytäntö lisätietoja varten.
Hylkää